Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 29, 2017

DrugPatentWatch Database Preview

NITROSTAT Drug Profile

« Back to Dashboard

What is the patent landscape for Nitrostat, and when can generics launch?

Nitrostat is a drug marketed by Pfizer Pharms and Parke Davis and is included in five NDAs. There is one patent protecting this drug and two Paragraph IV challenges.

This drug has thirteen patent family members in fifteen countries.

The generic ingredient in NITROSTAT is nitroglycerin. There are thirty-six drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. There are three tentative approvals for this compound. Additional details are available on the nitroglycerin profile page.

Summary for Tradename: NITROSTAT

Patents:1
Applicants:2
NDAs:5
Suppliers / Packagers: see list11
Bulk Api Vendors: see list16
Patent Applications: see list2,292
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:NITROSTAT at DailyMed

Pharmacology for Tradename: NITROSTAT

Ingredient-typeNitrates
Drug ClassNitrate Vasodilator
Physiological EffectVasodilation
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer Pharms
NITROSTAT
nitroglycerin
TABLET;SUBLINGUAL021134-001May 1, 2000ABRXYesNo6,500,456► Subscribe ► Subscribe
Parke Davis
NITROSTAT
nitroglycerin
INJECTABLE;INJECTION018588-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe
Parke Davis
NITROSTAT
nitroglycerin
INJECTABLE;INJECTION070863-001Jan 8, 1987DISCNNoNo► Subscribe► Subscribe
Parke Davis
NITROSTAT
nitroglycerin
INJECTABLE;INJECTION018588-002Dec 23, 1983DISCNNoNo► Subscribe► Subscribe
Pfizer Pharms
NITROSTAT
nitroglycerin
TABLET;SUBLINGUAL021134-002May 1, 2000ABRXYesNo6,500,456► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Predict branded drug patent expiration
  • Uncover prior art in abandoned patent applications and expired patents

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot